Four years of clinical experience with Radium-223 for the treatment of castration-resistant prostate cancer

por | Ene 1, 2019 | Publicaciones - CIMO-02 | 0 Comentarios

Perez, RMA; Garcia, AD; Martinez, SG; Viedma, SS; Gerona, HP; Vinardel, MP; Garcia, JMJH – 2019